Institutional & Family Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-94
| Closed | -$8K | – | 777 |
|
|
2021
Q4 | $8K | Hold |
94
| – | – | ﹤0.01% | 469 |
|
|
2021
Q3 | $7K | Hold |
94
| – | – | ﹤0.01% | 600 |
|
|
2021
Q2 | $8K | Hold |
94
| – | – | ﹤0.01% | 625 |
|
|
2021
Q1 | $7K | Sell |
94
-115
| -55% | -$8.56K | ﹤0.01% | 612 |
|
|
2020
Q4 | $18K | Hold |
209
| – | – | ﹤0.01% | 450 |
|
|
2020
Q3 | $16K | Hold |
209
| – | – | ﹤0.01% | 420 |
|
|
2020
Q2 | $26K | Sell |
209
-8
| -4% | -$995 | 0.01% | 372 |
|
|
2020
Q1 | $18K | Sell |
217
-2
| -0.9% | -$166 | ﹤0.01% | 378 |
|
|
2019
Q4 | $19K | Hold |
219
| – | – | ﹤0.01% | 435 |
|
|
2019
Q3 | $15K | Buy |
219
+3
| +1% | +$205 | ﹤0.01% | 426 |
|
|
2019
Q2 | $19K | Buy |
216
+59
| +38% | +$5.19K | ﹤0.01% | 424 |
|
|
2019
Q1 | $14K | Hold |
157
| – | – | ﹤0.01% | 456 |
|
|
2018
Q4 | $13K | Buy |
157
+10
| +7% | +$828 | ﹤0.01% | 435 |
|
|
2018
Q3 | $14K | Buy |
147
+13
| +10% | +$1.24K | ﹤0.01% | 476 |
|
|
2018
Q2 | $13K | Buy |
+134
| New | +$13K | ﹤0.01% | 480 |
|